| Business Summary | | Protide
Pharmaceuticals,
Inc.,
formerly
known
as
Celox
Laboratories,
Inc.,
is
a
cell
technology
company
that
researches,
develops,
manufactures,
and
markets
cell
biology
products
that
are
used
in
the
propagation
of
cells
derived
from
mammals,
including
humans,
and
other
species.
These
specialized
cell
growth
products
are
used
primarily
in
academic,
pharmaceutical
and
other
commercial
laboratories
to
improve
the
growth,
productivity
and
quality
of
cell-derived
medical
and
other
biological
products
such
as
vaccines,
monoclonal
antibodies,
interferons
and
human
growth
factor.
The
Company
markets
over
25
different
products.
The
Company's
proprietary
products
consist
of
six
different
serum-free
supplements,
TCM,
TM-235,
TCH,
Nephrigen,
HemaPro
and
VaxMax,
and
two
cell-freezing
solutions,
Cellvation
and
a
newly
introduced
product,
pZerve. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | PPMD
is
a
biotechnology
company
that
researches,
develops,
manufactures,
and
markets
cell
biology
products
that
are
used
in
the
propagation
of
cells
derived
from
mammals,
including
humans
and
other
species.
For
the
nine
months
ended
5/01,
revenues
rose
15%
to
$147
thousand.
Net
loss
fell
3%
to
$247
thousand.
Results
reflect
a
favorable
timing
of
orders
received
from
distributors
and
customers,
partially
offset
by
higher
S/G/A
costs. | More
from
Market Guide: Significant
Developments |
| Officers | | | FY2000 Pay | |
| Milo Polovina, 44 Chairman,
Pres, CEO, Treasurer, Sec. | $133K | Dollar amounts are as of 31-Aug-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|